Senior insider sale
EVP & GENERAL COUNSEL at UNITED THERAPEUTICS CORP — senior position signals high conviction
$27.59M
49.80K shares
What this filing means
MAHON PAUL A plans to sell 49.80K shares of UNITED THERAPEUTICS CORP valued at approximately $27.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/16/2026ACC: 0001950047-26-007152
Officer· EVP & GENERAL COUNSEL
Since Mar 2026
49.80K
Shares to sell
$27.59M
Approx. market value
8.30K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/16/2026
8.30KTotal acquired8.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/16/2026 | Stock Option Exercise Cash | 8.30K | — |
| Total | 8.30K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
8.30K
Market value
$4.59M
7/2/2026
—Completed
Units to sell
8.30K
Market value
$4.49M
6/18/2026
—Completed
Units to sell
8.30K
Market value
$4.54M
6/4/2026
—Completed
Units to sell
8.30K
Market value
$4.67M
5/21/2026
—Completed
Units to sell
8.30K
Market value
$4.87M
5/7/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.30K
Market value
$4.43M
7/16/2026
Total
Units
49.80K
Value
$27.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2026 | 8.30K | $4.59M | — | Completed |
6/18/2026 | 8.30K | $4.49M | — | Completed |
6/4/2026 | 8.30K | $4.54M | — | Completed |
5/21/2026 | 8.30K | $4.67M | — | Completed |
5/7/2026 | 8.30K | $4.87M | — | Completed |
| Planned — Approximate Date | ||||
7/16/2026 | 8.30K | $4.43M | NASDAQ | Planned |
| Total | 49.80K | $27.59M | ||